NEW YORK (GenomeWeb News) – Charles River Laboratories has completed its purchase of the BioFocus and Argenta service division operations from Galapagos for up to €134 million ($184 million). As part of the deal announced in March, Charles River paid Galapagos €129 million upfront and will pay potentially up to another €5 million upon the achievement of a revenue target 12 months after the closing of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.